Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik, J Aschan, O Ringden - Leukemia, 2001 - nature.com
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
[引用][C] Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J MATTSSON, M UZUNEL, L TAMMIK, J ASCHAN… - …, 2001 - pascal-francis.inist.fr
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients
with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell …
with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell …
[引用][C] Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J MATTSSON - Leukemia, 2001 - cir.nii.ac.jp
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients
with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell …
with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik… - Leukemia …, 2001 - search.ebscohost.com
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik, J Aschan, O Ringden - Leukemia, 2001 - go.gale.com
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik, J Aschan… - …, 2001 - pubmed.ncbi.nlm.nih.gov
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik, J Aschan, O Ringdén - Leukemia, 2001 - europepmc.org
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik… - Leukemia …, 2001 - search.ebscohost.com
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …